BGLAP and Insulin resistance: Undercarboxylated osteocalcin increases insulin sensitivity and secretion [27, 34–36], and serum levels of undercarboxylated osteocalcin negatively correlate with insulin resistance, obesity, and diabetes [7, 17, 37–39].